GLIDAPAFLOZIN TRIO 1 FORTE

GLIDAPAFLOZIN TRIO 1 FORTE is a powerful oral anti-diabetic medication combining Dapagliflozin, Glimepiride, and Metformin. This scientifically balanced formulation provides a comprehensive approach to managing type 2 diabetes mellitus by addressing multiple pathways of glucose regulation. It is especially beneficial for patients who require multi-drug therapy for optimal glycemic control.

By combining three complementary anti-diabetic agents in a single tablet, GLIDAPAFLOZIN TRIO 1 FORTE offers convenience, improved compliance, and better blood sugar management.

What is Dapagliflozin Glimepiride Metformin Tablet?

The Dapagliflozin Glimepiride Metformin Tablet is a triple-drug formulation used for the treatment of type 2 diabetes mellitus. Each component has a unique mechanism of action:

• Dapagliflozin (SGLT2 inhibitor): Promotes glucose excretion through the urine by blocking sodium-glucose co-transporter 2 in the kidneys.

• Glimepiride (Sulfonylurea): Stimulates the pancreas to release more insulin.

• Metformin (Biguanide): Improves insulin sensitivity and reduces hepatic glucose production.

Together, these agents lower blood glucose levels effectively, reduce HbA1c, and help minimize the risk of diabetes-related complications.

Uses of Dapagliflozin Glimepiride Metformin Tablet

The primary indications of GLIDAPAFLOZIN TRIO 1 FORTE include:

• Management of Type 2 Diabetes Mellitus in adults

• Used when single or dual therapy with antidiabetic drugs is insufficient

• Helps improve glycemic control in patients with poor blood sugar regulation

• May support weight reduction and blood pressure control as additional metabolic benefits

• Reduces the risk of cardiovascular events in some patients with coexisting heart conditions

Side Effects of Dapagliflozin Glimepiride Metformin Tablet

While GLIDAPAFLOZIN TRIO 1 FORTE is generally well-tolerated, some patients may experience side effects, including:

• Hypoglycemia (especially due to Glimepiride)

• Genital infections or urinary tract infections (due to Dapagliflozin)

• Nausea, vomiting, or diarrhea (Metformin-related)

• Headache or dizziness

• Dehydration or increased urination

• Weight loss

Rare but serious side effects:

• Lactic acidosis (from Metformin) – a medical emergency

• Severe hypoglycemia

• Ketoacidosis (though rare, especially with Dapagliflozin)

Report any unusual symptoms to your healthcare provider promptly.

Precautions Before Using GLIDAPAFLOZIN TRIO 1 FORTE

Before starting GLIDAPAFLOZIN TRIO 1 FORTE, consider the following precautions:

• Not recommended in patients with type 1 diabetes or diabetic ketoacidosis

• Use with caution in individuals with renal or hepatic impairment

• Inform your doctor if you have a history of urinary tract infections, genital infections, or pancreatic disorders

• Stay hydrated and monitor blood sugar levels regularly

• Do not use if you are pregnant or breastfeeding without medical supervision

• Avoid alcohol, which can increase the risk of lactic acidosis with metformin

What Drugs Interact with Dapagliflozin Glimepiride Metformin?

Certain drugs may affect the action of GLIDAPAFLOZIN TRIO 1 FORTE or increase the risk of side effects:

• Diuretics: May increase the risk of dehydration and hypotension

• Beta-blockers: Can mask symptoms of hypoglycemia

• ACE inhibitors / ARBs: May enhance the glucose-lowering effect

• Insulin or other sulfonylureas: Increase the risk of hypoglycemia

• Cimetidine: May increase metformin concentration

• Alcohol: Increases the risk of lactic acidosis

Always inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting this combination.

Conclusion

GLIDAPAFLOZIN TRIO 1 FORTE is a clinically effective combination of dapagliflozin, glimepiride, and metformin, specially designed to offer a multifaceted approach to blood glucose control in type 2 diabetes. It helps address insulin secretion, insulin sensitivity, and renal glucose reabsorption in one single dose.

Choose GLIDAPAFLOZIN TRIO 1 FORTE for:

 Better glycemic control
 Reduced pill burden
 Potential cardiovascular and renal benefits
 Backed by evidence and trusted by healthcare providers

Consult your doctor before starting this medicine to ensure it is appropriate for your medical needs and to determine the correct dosage.

If You Need More Information About GLIDAPAFLOZIN TRIO 1 FORTE   Click here